On the same day that Rhythm Pharmaceuticals presented data on its drug candidate to treat diabetic gastroparesis, it also announced results from a study it funded showing the condition is more common among diabetic patients in the U.S. than previously thought. Lee Kaplan, HMS associate professor of medicine at Massachusetts General Hospital, conducted the study.
News & Research
